In situ evaluation of gemcitabine–DNA interaction using a DNA-electrochemical biosensor
- 1 October 2014
- journal article
- research article
- Published by Elsevier BV in Bioelectrochemistry
- Vol. 99, 40-45
- https://doi.org/10.1016/j.bioelechem.2014.05.005
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective studyEuropean Journal of Cancer, 2013
- Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancerEuropean Journal of Cancer, 2011
- Anodic Oxidation of Cladribine and In Situ Evaluation of DNA-Cladribine InteractionElectroanalysis, 2011
- Nucleoside analogue electrochemical behaviour and in situ evaluation of DNA–clofarabine interactionBioelectrochemistry, 2011
- Gemcitabine chemotherapy for the treatment of metastatic bladder carcinomaBJU International, 2011
- Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinomaCancer, 2010
- GemcitabineAmerican Journal of Cancer, 2005
- Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II TrialJournal of Clinical Oncology, 2004
- Nucleoside analogues and nucleobases in cancer treatmentThe Lancet Oncology, 2002
- Advanced breast cancer: Investigational role of gemcitabineEuropean Journal of Cancer, 1997